USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
SERACARE LIFE SCIENCES, INC.
Address:
SERACARE LIFE SCIENCES, INC.
1935 AVENIDA DEL ORO, STE F
OCEANSIDE, MD 92056 0582
Phone:
(760) 806-8922
URL:
N/A
EIN:
43253991
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,567,829.00 22
SBIR Phase II $1,722,798.00 3
STTR Phase I $123,566.00 1

Award List:

THE GOAL OF PHASE I IS TO DETERMINE THE USEFULNESS OF A NEW SEPARATION TECHNIQUE FOR THE RAPID ISOLATION OF AFLATOXINS FROM FOOD COMMODITIES SUCH AS MILK AND GRAIN SOLVENT EXTRACTS.

Award Year / Program / Phase:
1983 / SBIR / Phase I
Award Amount:
$53,384.00
Agency:
HHS
Principal Investigator:
Anton f. steuer , PRINCIPAL INVESTIGATOR
Abstract:
The goal of phase i is to determine the usefulness of a new separation technique for the rapid isolation of aflatoxins from food commodities such as milk and grain solvent extracts. the separation technique termed electromolecular propulsion (emp) by its inventor norman haber will be evaluated with… More

PHASE I WILL INVOLVE ASCERTAINING THE FEASIBILITY OF A NOVEL ELECTROCHEMICAL IMMUNOSENSOR APPROACH.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$49,951.00
Agency:
HHS
Principal Investigator:
Anton f. steuer , PRINCIPAL INVESTIGATOR
Abstract:
Phase i will involve ascertaining the feasibility of a novel electrochemical immunosensor approach. electrodes in series and with electroactive reagents will be constructed and evaluated for their ability to detect haptens and antigens such as aflatoxin b1 and htlv-iii. an electrochemical… More

RECOMBINANT DNA TECHNIQUES WILL BE USED TO PRODUCE A SUBUNIT VACCINE FOR AIDS WHICH WILL RESEMBLE THE OUTER MEMBRANES OF HTLV-III VIRIONS OR HTLV-III INFECTED CELLS.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$49,877.00
Agency:
HHS
Principal Investigator:
Mark m. manak , PRINCIPAL INVESTIGATOR
Abstract:
Recombinant dna techniques will be used to produce a subunit vaccine for aids which will resemble the outer membranes of htlv-iii virions or htlv-iii infected cells. a recombinant dna vector will be constructed to contain the env region of the virus along with the 5 and 3 ltr's which are required… More

FOR THE PAST 40 YEARS, CLINICAL IMMUNE GLOBULIN AND ALBUMIN HAVE BEEN ISOLATED FROM PLASMA OR CRYOSUPERNATANT BY THE COLD ETHANOL PROCEDURE THROUGHOUT THE WORLD.

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Yulee hao , PRINCIPAL INVESTIGATOR
Abstract:
For the past 40 years, clinical immune globulin and albumin have been isolated from plasma or cryosupernatant by the cold ethanol procedure throughout the world. because of the excellent records of safety and efficacy of these two products, it is safe to assume that, in the foreseeable future, the… More

DEVELOPMENT OF AN ELISA TEST FOR ANTIBODIES TO HUMAN B-LYMPHOTROPHIC VIRUS

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Anne j bodner phd
Abstract:
Nih researchers have recently announced the isolation of a human b-lymphotropic virus (hblv) from six individuals with various lymphoproliferative and immune disorders. hblv appears to belong to the group of human herpes viruses and may be associated with b lymphoproliferative disorders. early… More

DEVELOPMENT OF NONRADIOACTIVE DNA PROBES FOR THE DETECTION OF HBLV

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$47,000.00
Agency:
HHS
Principal Investigator:
Sandra k dusing-swartz ph
Abstract:
A novel human b-lymphotropic virus (hblv) has been recently isolated from patients with lymphoproliferative disorders. this herpes virus has been shown to infect b and t lymphocytes and to alter their morphology and growth characteristics. the significance of the virus in causing human diseases has… More

S V ADENOVIRUS RECOMBINANTS FOR VACCINE EFFICACY

Award Year / Program / Phase:
1989 / SBIR / Phase I
Award Amount:
$49,305.00
Agency:
HHS
Principal Investigator:
Abstract:
A model vaccine system will be developed using recombinant dna technology and classic virology to construct a nondefective recombinant adenovirus that expresses the simian immunodeficiency virus (siv) envelope protein. vaccination of rhesus macaques with the recombinant siv-adenovirus and subsequent… More

DEVELOPMENT OF AN ANTIGEN CAPTURE ASSAY FOR HTLV-I

Award Year / Program / Phase:
1989 / SBIR / Phase I
Award Amount:
$49,891.00
Agency:
HHS
Principal Investigator:
Abstract:
Phase i research iill develop a prototype elisa antigen-capture kit to measure htlv-i core proteins p19 and p24 produced during virus replication in cells. htlv-i is linked to the development of adult t-cell leukemia and totropical spastic paraparesis, a neurological disease of interest to… More

USE OF DNA PROBES FOR THE DETECTION OF LYME DISEASE

Award Year / Program / Phase:
1990 / SBIR / Phase I
Award Amount:
$49,110.00
Agency:
HHS
Principal Investigator:
Mark M Manak
Abstract:
The treatment of lyme disease could be greatly enhanced if it were possible to detect the lyme disease spirochete directly in blood with a highly sensitive test. it is planned to develop a test where a region of the borrelia burgdorferi ospa gene is amplified using the polymerase chain reaction… More

SOLID PHASE PLATE ASSAY (SPPA) FOR HIV1 GENOTYPING

Award Year / Program / Phase:
1997 / SBIR / Phase I
Award Amount:
$99,971.00
Agency:
HHS
Principal Investigator:
Gonzalez-villasenor, luci
Abstract:
N/a

N/A

Award Year / Program / Phase:
1999 / SBIR / Phase II
Award Amount:
$653,517.00
Agency:
HHS
Principal Investigator:
Gonzalez-villasenor lucia
Abstract:
N/a

NATURAL PRODUCT DERIVATIVES THAT POTENTLY INHIBIT HIV1

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$99,988.00
Agency:
HHS
Principal Investigator:
Graham P. Allaway
Abstract:
Not Available Triton Systems proposes to combine its innovative polymer-clay nanotechnology with chemically resistant polymers to develop revolutionary flexible nanocomposite materials that will provide significant performance improvements and also reduce the cost of chemical and biological (CB)… More

DEVELOPMENT OF PCR BASED ASSAY FOR BABESIOSIS

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$99,891.00
Agency:
HHS
Principal Investigator:
Bita Nakhai
Abstract:
Not Available This Small Innovative Research Phase I proposal seeks to employ a new phenomena, high pressure electrokinetic (HPEK) pumping, for the development of embedded electronically activated actuator assemblies. The Phase I research will demonstrate the ability to obtain controlled, high… More

SOLID PHASE MICROPLATE ASSAYS FOR TTV

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$99,894.00
Agency:
HHS
Principal Investigator:
Jay J. Ji
Abstract:
N/a

CRYOBARIC INACTIVATION OF VIRAL CONTAMINANTS IN PLASMA

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$68,231.00
Agency:
HHS
Principal Investigator:
Robert A. Hess
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$99,998.00
Agency:
HHS
Principal Investigator:
Feng Tao
Abstract:
Not Available The Advanced Analysis Package for High Speed Multi-Bearing Shaft Systems for rolling bearing supported rotors has Unique Features and Capabilities typical of industries current design needs. Among these are loosely coupled interfaces with commercial FEA c

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$99,999.00
Agency:
HHS
Principal Investigator:
Feng Tao
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Sandra K. Dusing
Abstract:
N/a

Cryobaric Inactivation of Viral Contaminants in Plasma

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Nathan Lawrence
Abstract:
N/a

Cryobaric Inactivation of Viral Contaminants in Plasma

Award Year / Program / Phase:
2001 / SBIR / Phase II
Award Amount:
$371,188.00
Agency:
HHS
Principal Investigator:
Nathan Lawrence
Abstract:
N/a

TISSUE HOMOGENIZATON BY PRESSURE CYCLING TECHNOLOGY

Award Year / Program / Phase:
2002 / SBIR / Phase II
Award Amount:
$698,093.00
Agency:
HHS
Principal Investigator:
Abstract:
An application using pressure cycling technology (PCT) is being developed to lyse cells and homogenize tissues for automated biological sample processing. This technology is feasible for automated processes in both low and high throughput applications. Our Phase I study… More

TISSUE HOMOGENIZATON BY PRESSURE CYCLING TECHNOLOGY

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
An application using pressure cycling technology (PCT) is being developed to lyse cells and homogenize tissues for automated biological sample processing. This technology is feasible for automated processes in both low and high throughput applications. Our Phase I study… More

NOVEL DEVICES FOR COLLECTING AND PROCESSING MYCOBACTERIA

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$99,994.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This proposal describes the feasibility study of using Boston Biomedica, Inc.'s proprietary Pressure Cycling Technology (PCT), its instrument (Barocylcer) and its novel sample preparation tube (PULSE) to process sputum and Mycobacteria species for detection by… More

DETECTION OF PRION PROTEIN IN BLOOD

Award Year / Program / Phase:
2002 / STTR / Phase I
Award Amount:
$123,566.00
Agency:
HHS
Principal Investigator:
Research Institution:
UNIVERSITY OF MARYLAND
RI Contact:
N/A
Abstract:
Prion diseases are 100 percent fatal, there is no treatment available, and cannot be diagnosed prior to the occurrence of symptoms. There is a public health need and an enormous market for a screening test that can help protect the blood supply, screen live animals, and ensure food safety. We… More

'APO-ARREST': A NEW APOPTOTIC INHIBITOR

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$101,369.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Some epidemiological studies are so large that it would be too expensive to isolate peripheral blood mononuclear cells (PBMCs) from every donor enrolled in them. Therefore, research studies, such as the Retrovirus Epidemiology Donors Study (REDS) have collected… More

Novel Devices for Processing Bioterrorism Agents

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$149,976.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by investigator): This application describes the feasibility study of using Boston Biomedica, Inc.'s proprietary Pressure Cycling Technology (PCT), its instrument (BarocylcerTM) and its novel sample preparation tube (PULSE) as a new method to collect, transport, store, grow… More